ABOUT USdot CONTACTdot LOG IN

Archives for the 'news2' Category

South Korean FDA Approves Cynosure’s Accolade Workstation for Pigmented Lesions

Although freckles occur most often in light skinned individuals with blond hair and blue eyes, freckles are also common among Asians, including Koreans. While they can look good, I’ve learned in my 25 years to never get between a woman and her happiness.
Cynosure, based in Westford, MA, offers an array of laser-based aesthetic treatment systems. […]

7 May 2008 | Blog, news2 | No Comments

[Video Profile] Interview with Ralph Makar, President & CEO of Bioject Medical

Bioject Medical develops and markets needle-free injection technology used to administer injectable medications.
Bioject’s technology works by forcing liquid medication at high speed through a tiny orifice (smaller than a human hair) held against the skin. This creates an ultra-fine stream of fluid that penetrates the skin in a fraction of a second. Several studies have […]

5 May 2008 | Executive Summary, Blog, Member Spotlight, news2, Video | No Comments

Bad News for Blood Substitutes

Blood substitutes don’t require refrigeration or cross-matching, have a long shelf life, and reduce the risk of iatrogenic infection. They could be a potentially lifesaving option for surgical and trauma patients with hemorrhagic shock, especially in rural areas and military settings where access to donor blood is limited.
Despite the potential advantages, clinical trials have raised […]

2 May 2008 | Blog, news2 | No Comments

CryoLife on Firm Footing: EPS Increases, Revenues Up, Raises Guidance

Revenues at CryoLife rose 4% to $25.6 million in the first quarter of 2008. Net income was $2.8 million, or $0.10 per share, compared to $1.4 million, or $0.04 per share in Q1 2007.
Tissue processing revenues in Q1 2008 increased 4% to $13.4 million, primarily due to increased demand for the company’s cardiac and vascular […]

1 May 2008 | Blog, Member Spotlight, news2 | No Comments

NeuroMetrix Receives FDA 510(k) Clearance for Advance

Long beleaguered NeuroMetrix, which has seen its stock price erode as officials investigate the marketing and misuse of its NC-stat System, received FDA 510(k) clearance for the Advance System this week. Shares of the Waltham, MA-based company nearly doubled on the news, to a high of $3.06 on Monday.

Advance is a platform for performing nerve […]

30 April 2008 | Blog, news2 | No Comments

Merit Medical: Shows Resilience in Faltering Economy; Positioned for Continued Growth

The healthcare equipment sector has a history of resilience. The sector remained strong during the economic downturn earlier this decade and appears to be holding its own now. An aging demographic virtually guarantees increased demand for healthcare supplies.
Not surprisingly, the sector is also highly competitive. J&J, Boston Scientific and Medtronic are industry behemoths with a […]

28 April 2008 | Blog, news2 | No Comments

Yulex Receives FDA 510(k) Clearence for Novel Rubber Glove

Latex glove use increased dramatically in the eighties largely as an outgrowth of the AIDS epidemic. Almost unheard of 20 years ago, researchers now estimate that 8% - 12% of healthcare workers have developed allergies to traditional latex.
In one well-cited study of blood donors, more than 6% had evidence of latex antibodies. Extrapolated to the […]

25 April 2008 | Blog, news2 | No Comments

Biophan Moves Forward with Myotech CSS Development

Pittsford, NY-based Biophan Technologies, will move forward with the next phase of the Myotech Circulatory Support System (CSS) engineering and regulatory development program.
The company’s board released $2 million to support efforts which will bring the product closer to commercialization. According to the company, Myotech CSS could be on the market within 24 to 30 months.
The […]

24 April 2008 | Blog, news2 | No Comments

[Video Profile] Interview with Leah Sparks, VP Business Development of DNA Direct

Medical professional societies have mandated that genetic tests be ordered by a physician and interpreted by a genetic counselor, geneticist, or other specialist. In some states, genetic testing must be accompanied by an in-person genetics evaluation or genetic counseling appointment.
This approach is limited by the fact that there are only 1,200 medical geneticists and […]

22 April 2008 | Executive Summary, Blog, news2, Video | 1 Comment

Natus Further Consolidates U.S. Newborn Hearing Loss Screening Market with SonaMed Acquisition

Natus Medical announced yesterday that it will acquire SonaMed, a privately held company based in Waltham, MA.
SonaMed manufactures and markets the Clarity Screener for the screening of hearing loss in newborns. The company reported revenues of $3.5 million in 2007.
According to Jim Hawkins, Natus’ President and CEO, “SonaMed has successfully created a distinct presence in […]

16 April 2008 | Blog, news2 | No Comments

Navigation

Archives

Meta

Search

Seeking Alpha Certified
Equities Building Research Building Enterprises Building Resources Building blog counter